Phase II trial: mitomycin c and methotrexate combination therapy for advanced colorectal carcinoma.
D000328:Adult; D000368:Aged; D003110:Colonic Neoplasms / Q000188:drug therapy*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage*; D008875:Middle Aged; D008937:Mitomycins / Q000008:administration & dosage*; D009362:Neoplasm Metastasis; D012004:Rectal Neoplasms / Q000188:drug therapy*
D008937:Mitomycins; D008727:Methotrexate